Ocugen, Inc. (OCGN)

NASDAQ: OCGN · USD

$0.78

+0.02 (+2.9%)· Recorded snapshot

Market cap	264.4M
Revenue (ttm)	4.6M
Net income (ttm)	-81.8M
EPS (ttm)	-$0.26
Shares out	339.1M
Volume	8,677,893
Beta	2.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.6M
Net income (ttm): -81.8M
EPS (ttm): -$0.26
Market cap: 264.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-80.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All OCGN indicators

Market & fundamental data

Available fields

191

Groups with data

Currency

USD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001372299
Company name	Ocugen, Inc.
Country	United States
Country code	US
CUSIP number	67577C105
Earnings date	2026-11-04
Earnings time	bmo
Employees	116
Employees change	21
Employees growth	22.11%
Enterprise value	$252.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US67577C1053
Last 10-K release date	2026-03-04
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$264.4M
Market cap category	Micro-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$0.78
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	OCGN
U.S. state	Pennsylvania
Website	https://www.ocugen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-32.72%
EV/Sales	53.29x
FCF / EV yield	-25%
FCF yield	-23.82%
Forward EV/Sales	68.96x
Forward P/S	72.37x
P/S ratio	55.93x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-1,504.08%
Pretax margin	-1,785.88%
Profit per employee	$-705,267
Revenue per employee	$39,491
ROA	-48.44%
ROA (5Y)	-52.54%
ROCE	776.45%
ROE (5Y)	-248.55%
ROIC	-80.26%
SBC / revenue	201%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth	-3.64%
Revenue growth (Q)	8.38%
Revenue growth (QoQ)	-2.94%
Revenue growth 3Y	10.28%
Revenue growth quarters	2
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-153,000
Depreciation and amortization	$1.7M
EBIT	$-68.9M
EBITDA	$-67.2M
EPS	$-0.26
FCF per share	$-0.18
Financing cash flow	$133.9M
Free cash flow	$-61M
Free cash flow minus SBC	$-70.2M
Gross profit	$-39.2M
Investing cash flow	$-148,000
Net borrowing	$84.3M
Net cash flow	$73M
Net income	$-81.8M
Operating cash flow minus SBC	$-70.1M
Operating income	$-68.9M
Revenue	$4.6M
Stock-based compensation	$9.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-5.17
Book value per share	$-0.05
Interest coverage	-8.16
Long-term assets	$17.5M
Long-term liabilities	$7.7M
Net cash (debt)	$12.1M
Net cash / market cap	4.71%
Piotroski F-Score	2
Property, plant and equipment	$13.3M
Shareholders' equity	$-16.6M
Tangible book value	$-16.6M
Tangible book value per share	$-0.05
Total assets	$124.2M
Total cash	$100.1M
Total debt	$88M
Total liabilities	$140.8M
WACC	14.39%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.05
Current assets	$106.7M
Current liabilities	$133.1M
Current ratio	0.8
Net working capital	$-43.2M
Quick ratio	0.75
Working capital	$-26.4M
Working capital turnover	-0.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-11.22%
Dividend yield	0%
Shareholder yield	-11.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.34
1D price change	2.93%
1M price change	-26.23%
1M total return	-26.23%
1W price change	-7.38%
1W total return	-7.38%
1Y price change	-51.76%
1Y return CAGR	-51.79%
1Y total return	-51.76%
20-day SMA	$0.87
200-day SMA	$1.44
3M price change	-40.28%
3M total return	-40.28%
3Y price change	109.61%
3Y return CAGR	27.97%
3Y total return	109.61%
50-day SMA	$1.06
50-day SMA vs 200-day SMA	50under200
52-week high	$2.73
52-week high date	2026-03-17
52-week low	$0.70
52-week low date	2026-10-26
5Y price change	-92.17%
5Y return CAGR	-39.92%
5Y total return	-92.17%
6M price change	-55.74%
6M total return	-55.74%
All-time high	$18.77
All-time high date	2021-02-08
All-time low	$0.17
All-time low date	2020-06-01
Average true range (ATR)	$0.06
Average volume	6.8M
Beta (1Y)	0.71
Beta (2Y)	1.05
Beta (5Y)	2.27
Change from 52-week high	-71.39%
Change from 52-week low	11.12%
Change from all-time high	-95.99%
Change from all-time low	342.65%
Change from open	1.25%
Day's gap	1.66%
Dollar volume	$6.8M
High price	$0.80
Low price	$0.75
Monthly RSI	40.41
Open price	$0.77
Position in 52-week range	58.3%
Premarket change	2.96%
Premarket close	$0.76
Premarket price	$0.78
Premarket volume	107.4K
Previous close	$0.76
Price vs 150-day SMA	-43.72%
Price vs 20-day SMA	-13.82%
Price vs 200-day SMA	-47.74%
Price vs 50-day SMA	-29.14%
Relative volume	1.28
RSI	30.64
Sharpe ratio	-0.59
Sharpe ratio (3Y)	0.62
Sharpe ratio (5Y)	-0.15
Sortino ratio	-0.78
Sortino ratio (3Y)	1.08
Sortino ratio (5Y)	-0.15
Volume	8.7M
Weekly RSI	33.44
YTD price change	-44.26%
YTD total return	-44.26%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	334.3M
Float percentage	98.58%
Shares change (QoQ)	3.4%
Shares change (YoY)	11.22%
Shares held by insiders	1.42%
Shares held by institutions	43.28%
Shares outstanding	339.1M
Short % of float	30.53%
Short % of shares	30.09%
Short ratio	11.8 days

Deeper analysis on OCGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OCGN report

Is a complete OCGN research report available?

No complete published report is available for Ocugen, Inc. (OCGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Ocugen, Inc. (OCGN)

Price

Financial snapshot

Fair-value bridge

Latest news · OCGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OCGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OCGN

Frequently asked questions